Astria Therapeutics, Inc. (NASDAQ:ATXS) filed a Form 8-K with the Securities and Exchange Commission on January 21, 2026, disclosing a material event.
Astria Therapeutics, Inc.'s stock currently trades at $12.50 with a market capitalization of $737.5M. The Healthcare company's stock moved following the disclosure.